tive tax rates. We may be subject to audits of our income, sales, and other transaction taxes by U.S. federal, state, and local taxing authorities. Outcomes from these audits could have a material ef…
Reciprocal relationship from STT-PG graph: Reciprocal relationship from ADMA graph: Reciprocal relationship from STT-PG graph: Reciprocal relationship from ADMA graph: tive tax rates. We may be subje…
he out-licensing of ASCENIV to Biotest AG (“Biotest”) in 2012 to market and sell this product in Europe and certain countries in Northern Africa and the Middle East. Biotest has provided the Company …
ioCare”) and Priority Healthcare Distribution, Inc. d/b/a CuraScript SD Specialty Distribution (“Curascript”), represented an aggregate of approximately 71% and 64%, respectively, of our consolidated…
ADMA Biologics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
ADMA-DEBT
Debt stack $97.7B
90%
Market cache reports total debt of $97.7B.
ADMA-DEBT-7512
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2012-12-31.
ADMA-DEBT-7511
Warrants outstanding: 966554
90%
xbrl warrant detail from xbrl 2025-12-31.
ADMA Biologics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for ADMA Biologics, Inc..
ADMA Biologics, Inc. Ownership
Holder
Name
Confidence
Evidence
ADMA-OWNER-BLACKROCK-INC
BlackRock, Inc.
90%
13F overlay lists BlackRock, Inc. as top holder; 360 tracked holders.
ADMA Biologics, Inc. Extended Supply Chain Network
